+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Infection Drug"

Zika Virus Infection - Pipeline Insight, 2025 - Product Thumbnail Image

Zika Virus Infection - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Chikungunya - Pipeline Insight, 2025 - Product Thumbnail Image

Chikungunya - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Chronic Hepatitis C Virus Infection - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Hepatitis C Virus Infection - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 75 Pages
  • Global
From
From
From
Rabies Infection - Pipeline Insight, 2025 - Product Thumbnail Image

Rabies Infection - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Pseudomonas Aeruginosa Infection - Pipeline Insight, 2025 - Product Thumbnail Image

Pseudomonas Aeruginosa Infection - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Chronic Pulmonary Infections- Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Pulmonary Infections- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Chronic Hepatitis Delta Virus (HDV) Infection - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Hepatitis Delta Virus (HDV) Infection - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Nontuberculous Mycobacterial Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Nontuberculous Mycobacterial Infections - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Pseudomonal Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Pseudomonal Infections - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 50 Pages
  • Global
From
From
Parainfluenza Virus Infection - Pipeline Insight, 2025 - Product Thumbnail Image

Parainfluenza Virus Infection - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Helicobacter Pylori Infection - Pipeline Insight, 2025 - Product Thumbnail Image

Helicobacter Pylori Infection - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Klebsiella Pneumoniae Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Klebsiella Pneumoniae Infections - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Chlamydia Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Chlamydia Infections - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Prosthetic Joint Infections- Pipeline Insight, 2025 - Product Thumbnail Image

Prosthetic Joint Infections- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Acinetobacter Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Acinetobacter Infections - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Surgery Incisional Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Surgery Incisional Infections - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Adenovirus Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Adenovirus Infections - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Loading Indicator

The Infectious Diseases Drugs market is a subset of the pharmaceutical industry that focuses on the development and production of drugs used to treat infectious diseases. These drugs are used to treat a wide range of infections, including bacterial, viral, fungal, and parasitic infections. The market is highly competitive, with many companies vying for market share. Companies in the market are typically focused on developing new drugs, as well as improving existing treatments. Additionally, many companies are involved in the production of generic drugs, which are often cheaper than brand-name drugs. Companies in the Infectious Diseases Drugs market include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, Novartis, Johnson & Johnson, and Bristol-Myers Squibb. Show Less Read more